梅波利祖马布在患有鼻息肉的慢性鼻炎:在一个多中心的西西里亚体验中的真实生活数据
Cosimo Galletti1, Federico Sireci2, Giovanna Stilo3
1Faculty of Medicine and Surgery, University of Enna "Kore", 94100 Enna, Italy; Department of Adult and Development Age Human Pathology "Gaetano Barresi", Unit of Otorhinolaryngology, University of Messina, Via Consolare Valeria 1, 98125 3, Italy.
American journal of otolaryngology
|January 18, 2025
概括
梅波利祖马布显著改善了慢性鼻炎与鼻息肉 (CRSwNP) 患者的生活质量和减少了症状. 这项实践研究证实了mepolizumab在CRSwNP治疗中的有效性和安全性.
科学领域:
- 免疫学 免疫学 免疫学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 临床医学 临床医学
背景情况:
- 带有鼻息肉的慢性鼻鼻炎 (CRSwNP) 与2型炎症有关.
- 针对性治疗方法梅波利祖马布于2021年被批准用于CRSwNP.
- 关于梅波利祖马布在CRSwNP中的有效性的现实数据有限.
研究的目的:
- 评估mepolizumab在CRSwNP患者中的实际有效性.
- 评估mepolizumab在第一年使用期间的安全性.
- 分析症状严重程度,生活质量和嗅觉功能的变化.
主要方法:
- 这是一项多中心观察队列研究,涉及67名CRSwNP患者.
- 收集的数据包括人口统计,治疗史,过敏状况,血液中氨基酸蛋白,鼻息肉评分 (NPS),SNOT-22和气味测试.
- 统计分析使用威尔科克森测试对依赖样本进行分析,在p < 0.05时具有显著性.
主要成果:
- 在6个月和12个月后观察到SNOT-22分数和NPS显著减少 (p < 0.001).
- 通过Sniffin'sticks测试评估的嗅觉功能在6个月和12个月显著改善 (p < 0.001).
- 所有患者在12个月后继续接受梅波利祖马布治疗,因为减少了NPS,改善了生活质量,并减少了对全身皮质类固醇的需求.
结论:
- 梅波利祖马布有效改善生活质量,减少症状严重程度,多体大小,并增强严重CRSwNP的嗅觉功能.
- 现实世界的数据支持在CRSwNP患者中治疗美波利祖马布的安全性概况有利.
- 梅波利祖马布代表了一种有价值的治疗选择,用于管理严重的不受控制的CRSwNP.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
236
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
236
01:17Drugs Used in Lower Respiratory Disorders: Overview
349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349